Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Finished Goods (2017 - 2018)

Historic Finished Goods for BeOne Medicines (BEIGF) over the last 2 years, with Q2 2018 value amounting to $6.3 million.

  • BeOne Medicines' Finished Goods changed N/A to $6.3 million in Q2 2018 from the same period last year, while for Jun 2018 it was $6.3 million, marking a year-over-year change of. This contributed to the annual value of $10.9 million for FY2017, which is N/A changed from last year.
  • According to the latest figures from Q2 2018, BeOne Medicines' Finished Goods is $6.3 million.
  • Over the past 5 years, BeOne Medicines' Finished Goods peaked at $10.9 million during Q4 2017, and registered a low of $5.7 million during Q3 2017.